Abivax Sa ADR
(ABVX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||
| Net Income | -190,712 | -159,899 | -63,996 |
| Depreciation Amortization | 1,190 | 765 | 511 |
| Accounts receivable | 4,968 | -15,402 | 329 |
| Accounts payable and accrued liabilities | -3,727 | 34,371 | -2,516 |
| Other Working Capital | 3,072 | 21,763 | -13,506 |
| Other Operating Activity | 18,487 | 13,279 | 22,351 |
| Operating Cash Flow | $-166,721 | $-105,124 | $-56,827 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -693 | -287 | -303 |
| Purchase Sale Intangibles | -3 | N/A | -37 |
| Other Investing Activity | 17,749 | -8,474 | -12,367 |
| Investing Cash Flow | $17,056 | $-8,761 | $-12,671 |
| Cash Flows From Financing Activities | |||
| Debt Issued | 51,880 | 60,437 | N/A |
| Debt Repayment | -9,468 | -29,426 | N/A |
| Common Stock Issued | 470 | 382,474 | 48,863 |
| Other Financing Activity | -12,359 | -50,601 | -14,925 |
| Financing Cash Flow | $30,523 | $362,884 | $33,938 |
| Exchange Rate Effect | 2,578 | -5,489 | N/A |
| Beginning Cash Position | 272,626 | 29,168 | 63,955 |
| End Cash Position | 156,062 | 272,677 | 28,395 |
| Net Cash Flow | $-116,565 | $243,509 | $-35,560 |
| Free Cash Flow | |||
| Operating Cash Flow | -166,721 | -105,124 | -56,827 |
| Capital Expenditure | -693 | -287 | -303 |
| Free Cash Flow | -167,414 | -105,411 | -57,130 |